2022-RA-839-ESGO Recurrence of endometrial carcinoma: diagnosis in asymptomatic phase compared with symptomatic recurrence. Does it have any impact? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

Endometrial cancer

2022-RA-839-ESGO Recurrence of endometrial carcinoma: diagnosis in asymptomatic phase compared with symptomatic recurrence. Does it have any impact?

Free

Authors

Maria Dolores Rodriguez Garnica Obstetrics and Gynecology, Hospital Costa del Sol, Marbella, Málaga, Spain PubMed articles Google scholar articles
Elga López Gónzalez Hospital Juan Ramón Jiménez, Huelva, Spain PubMed articles Google scholar articles
Rocio Garcia Berrio Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain PubMed articles Google scholar articles
Laura Fernández Muñoz Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain PubMed articles Google scholar articles
Alvaro Zapico Goñi Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain PubMed articles Google scholar articles

Citation

Rodriguez Garnica MD, Gónzalez EL, Berrio RG, et al

2022-RA-839-ESGO Recurrence of endometrial carcinoma: diagnosis in asymptomatic phase compared with symptomatic recurrence. Does it have any impact?

International Journal of Gynecologic Cancer 2022;32:A114.

Publication history

First published October 20, 2022.

Online issue publication

October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.